If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
240.00    3.00 (1.27%)
Bid:
240.00
Ask:
245.00
Spread: 5.00 (2.083%)
Market Cap: £76.77m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

20 Apr 2026 16:32

RNS Number : 1867B
Braemar PLC
20 April 2026
 

 

20 April 2026

BRAEMAR PLC

("Braemar" the "Company")

 

PDMR Share Dealing

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces that on 17 April 2026, James Gundy, Group Chief Executive Officer, exercised 218,750 nil cost options ("Options") granted under the Company's Long Term Incentive Plan ("LTIP") as set out below:

 

LTIP award grant date

 

Vesting date

Two-year holding period end date

 

Number of Options exercised

24 July 2020

24 July 2023

24 July 2025

218,750

 

 

The 2020 LTIP award vested following the assessment of the applicable performance conditions which were disclosed in the 2023 remuneration report (page 83), this report is available on the Company's website at Financial Reports - Braemar.

 

The exercise of the Options under the LTIP, has been satisfied through the allocation of existing ordinary shares held by the Braemar Employee Share Ownership Plan; as such, no new ordinary shares have been issued. In order to cover tax and national insurance liabilities arising from the exercise of the Options, James Gundy sold 103,088 shares on 17 April 2026 and retained the balance of 115,662 shares.

Following the above transactions, James Gundy's total shareholding is now 1,139,695 (being 3.4% of the Company's issued share capital).

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, contact:

 

Braemar Plc

Tel: +44 (0)20 3142 4100

James Gundy, Group Chief Executive Officer

Grant Foley, Group Chief Financial & Operating Officer

Rebecca-Joy Wekwete, Company Secretary

Houston

Tel: +44 (0)20 4529 0549

Kate Hoare / Charlie Barker / Polly Clarke

Tel: +44 (0)77 3303 2695

braemar@houston.co.uk

Canaccord Genuity

Tel: +44 (0) 20 7523 8000

Adam James / Harry Rees

 

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

James Gundy

 

Reason for the notification

Position/status

Group Chief Executive Officer

 

Initial notification /Amendment

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

Name

Braemar Plc

 

LEI

213800EV6IKTTHJ83C19

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Exercise of Options granted under the Company's LTIP in 2020

Price(s) and volume(s)

Price: £0.00

 

Volume: 218,750

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £0.00

 

Volume: 218,750

Date of the transaction

17 April 2026

 

Place of the transaction 

Exercise of Options occurred outside a trading venue

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 10 pence each

Identification code

 

GB0000600931

Nature of the transaction 

 

Sale of shares to cover tax and national insurance following exercise of Options granted under the Company's LTIP in 2020

 

Price(s) and volume(s)

Price: £2.202792

 

Volume: 103,088

 

Aggregated information

 - Price

 

- Aggregated volume

 

 

Price: £227,081.42

 

Volume: 103,088

Date of the transaction

17 April 2026

 

Place of the transaction 

London Stock Exchange (XLON)

 

 

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice to the shipping and energy markets that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZGZDKGGGVZM
Date   Source Headline
10th May 201210:20 amRNSHolding(s) in Company
8th May 20127:00 amRNSFinal Results
30th Apr 201212:09 pmRNSTotal Voting Rights
30th Mar 20123:02 pmRNSTotal Voting Rights
22nd Feb 20123:57 pmRNSTotal Voting Rights
17th Feb 20122:46 pmRNSDirector/PDMR Shareholding
9th Feb 201212:18 pmRNSAdditional Listing and Total Voting Rights
8th Feb 20122:38 pmRNSAdditional Listing
7th Feb 20122:28 pmRNSAdditional Listing
3rd Feb 20125:34 pmRNSDirector/PDMR Shareholding
3rd Feb 201210:19 amRNSAdditional Listing
25th Jan 20122:09 pmRNSTotal Voting Rights
25th Jan 201211:19 amRNSBlocklisting Six Monthly Return
25th Jan 201211:12 amRNSBlocklisting Six Monthly Return
19th Jan 20129:13 amRNSHolding(s) in Company
12th Jan 20127:00 amRNSInterim Management Statement
14th Dec 201112:28 pmRNSDirectorate Change
17th Nov 20112:00 pmRNSAvailability of Half Yearly Report
28th Oct 20114:40 pmRNSSecond Price Monitoring Extn
28th Oct 20114:35 pmRNSPrice Monitoring Extension
25th Oct 20117:00 amRNSHalf Yearly Report
12th Sep 20117:00 amRNSTrading Update
13th Jul 201112:05 pmRNSTotal Voting Rights
13th Jul 201110:03 amRNSBlocklisting Six Monthly Return
13th Jul 20119:53 amRNSBlocklisting Six Monthly Return
23rd Jun 201112:04 pmRNSResult of General Meeting
22nd Jun 201112:00 pmRNSInterim Management Statement
7th Jun 201112:32 pmRNSAnnual Information Update
25th May 201112:21 pmRNSHolding(s) in Company
20th May 20113:33 pmRNSPosting of Annual Report and AGM Notice
20th May 201110:42 amRNSHolding(s) in Company
19th May 20113:49 pmRNSDirector/PDMR Shareholding
18th May 20113:46 pmRNSHolding(s) in Company
18th May 20113:40 pmRNSTotal Voting Rights
12th May 20113:13 pmRNSReplacement - Director/PDMR Shareholding
12th May 20111:40 pmRNSDirector/PDMR Shareholding
9th May 20117:05 amRNSAcquisition
9th May 20117:00 amRNSFinal Results
28th Apr 201110:18 amRNSNotice of Results
1st Feb 20113:56 pmRNSDirector/PDMR Shareholding
1st Feb 20117:00 amRNSTotal Voting Rights
17th Jan 20112:37 pmRNSBlocklisting Six Monthly Return
17th Jan 20112:35 pmRNSBlocklisting Six Monthly Return
12th Jan 20117:00 amRNSIMS & appointment of non-executive director
1st Dec 201010:22 amRNSHolding in Company
5th Nov 201012:24 pmRNSChange of Auditor
4th Nov 20105:14 pmRNSHolding(s) in Company
3rd Nov 20102:05 pmRNSDirector/PDMR Shareholding
26th Oct 20107:00 amRNSHalf Yearly Report
26th Oct 20107:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.